Caution
: A kink could cause damage to the device or patient injury.
Caution:
Do not exert excessive force when withdrawing or advancing the
catheter. If resistance is encountered determine if remedial action is necessary.
Failure to do so may result in device damage or patient injury.
2.
Adjust the Dispersion Wire rotation speed as desired.
3.
Continue the infusion procedure.
4.
After approximately one third of the total treatment is complete, check to determine that
desired agent dispersion has been achieved. If adequate dispersion has not been achieved,
it may be necessary to repeat the infusion and dispersion of the agent.
NOTE:
Resheath the Dispersion Wire by moving the Guide Wing from Position 2 to
Position 1 in the Mating Alignment Channel prior to advancing the Dispersion Wire Tip
to the desired position and repeat Procedural Steps 1-3.
5.
With approximately half of the vessel’s targeted infusion length remaining, slide the
access device to the most proximal end of the catheter assembly.
6.
While the catheter is still within the vessel, use vascular imaging to verify that the desired
outcome has been achieved.
7.
Re-sheath the Dispersion Wire Tip by moving the Guide Wing to Position 1 before
removing catheter from the patient. Disable the MDU:
a.
Disengage
the syringe from the Syringe Locking Support on the MDU. (Figure
2, 9)
b.
Rotate the catheter assembly to unlock from Position 2. (Figure 4)
c.
Move the Catheter Assembly Guide Wing’s Cartridge to the mating alignment
channel Position 1. (Figure 4)
NOTE:
Moving the Guide Wing into mating alignment channel Position 1 will
re-sheath the Dispersion Wire Tip and prevent the wire from rotating while
removing device from patient.
NOTE:
The Catheter Assembly
cannot
be separated from the MDU.
Post-Procedure:
1.
Dispose of the products and packaging per institutional protocol.
2.
Institute appropriate post-procedural patient care.
ELECTROMAGNETIC COMPATABILITY
Medical Electrical Equipment needs special precautions regarding EMC and needs to be installed and put
into service according to the EMC information provided in the accompanying documents. Portable and
Mobile RF communications equipment can effect medical electrical equipment.
WARNING
The use of accessories, other than those specified, may result in increased emissions or
decreased immunity of the equipment. The equipment should not be used adjacent to other equipment; and
if adjacent to the equipment should be observed to verify normal operation in the configuration in which it
will be used.
____________________________________________________________________
ClariVein
®
is a registered trademark of Vascular Insights
™
, LLC in the United States.
Page 8